[1]
“MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023003, Dec. 2022, doi: 10.4084/MJHID.2023.003.